Evofem Biosciences, Inc. (EVFM)

Evofem Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	-	-	2.77	7.73	48.89	15.57
Short-Term Investments	0.2	-	-	-	-	8.23
Cash & Short-Term Investments	0.2	-	2.77	7.73	48.89	23.8
Cash Growth	-	-	-64.19%	-84.19%	105.39%	1689.77%
Accounts Receivable	5.39	5.74	1.13	6.45	1.07	-
Other Receivables	-	-	-	-	-	0.44
Receivables	5.39	5.74	1.13	6.45	1.32	0.69
Inventory	1.46	1.7	5.38	7.67	7.16	-
Prepaid Expenses	0.63	0.78	1.39	2.6	16.7	0.97
Restricted Cash	0.72	0.58	1.21	5.06	22.56	0.3
Other Current Assets	0.17	0.42	0.83	0.63	1.1	0.66
Total Current Assets	8.58	9.21	12.7	30.14	97.73	26.42
Property, Plant & Equipment	1.31	1.31	8.35	11.17	11.19	0.55
Other Long-Term Assets	0.04	0.04	4.12	1.2	1.05	1.07
Total Assets	23.94	10.55	25.16	42.51	109.97	28.3
Accounts Payable	16.86	17.02	14.98	10.32	10.64	6.01
Accrued Expenses	8.35	6.84	6.3	13.72	10.99	6.45
Short-Term Debt	14.45	14.73	39.42	81.72	52.41	-
Current Portion of Long-Term Debt	30.2	28.54	26.27	27.21	-	-
Current Portion of Leases	0.12	0.1	2.31	2.33	2.29	0.2
Other Current Liabilities	6.31	5.24	4.55	2.37	0.95	-
Total Current Liabilities	76.29	72.46	93.83	137.66	77.28	12.66
Long-Term Debt	-	-	-	-	25.21	-
Long-Term Leases	0.01	0.01	3.13	4.42	6.03	-
Other Long-Term Liabilities	13.78	-	-	-	0.1	-
Total Liabilities	90.07	72.47	96.96	142.09	108.62	12.66
Common Stock	0.01	0	-	0.02	0.01	0.01
Additional Paid-In Capital	825.43	823.04	817.37	751.26	656.83	528.81
Retained Earnings	-894.62	-888.7	-938.69	-860.68	-655.49	-513.18
Comprehensive Income & Other	-1.71	-0.85	49.53	5.09	-	-
Total Common Equity	-70.89	-66.51	-71.8	-104.32	1.35	15.64
Shareholders' Equity	-66.13	-61.92	-71.8	-99.58	1.35	15.64
Total Liabilities & Equity	23.94	10.55	25.16	42.51	109.97	28.3
Total Debt	44.78	43.37	71.13	115.68	85.94	0.2
Net Cash (Debt)	-44.58	-43.37	-68.36	-107.95	-37.05	23.61
Net Cash Per Share	-0.86	-0.04	-146.70	-1546.16	-1034.37	1100.30
Filing Date Shares Outstanding	100.33	45.94	1.73	0.09	0.04	0.03
Total Common Shares Outstanding	100.33	20.01	0.98	0.09	0.04	0.03
Working Capital	-67.71	-63.25	-81.13	-107.52	20.45	13.76
Book Value Per Share	-0.71	-3.32	-72.91	-1203.63	31.05	609.02
Tangible Book Value	-84.91	-66.51	-71.8	-104.32	1.35	15.64
Tangible Book Value Per Share	-0.85	-3.32	-72.91	-1203.63	31.05	609.02
Machinery	0.73	1.23	2.17	2.15	1.7	0.83
Construction In Progress	1.15	1.16	1.57	2.41	2.25	0.08
Leasehold Improvements	-	-	3.39	3.39	1.54	0.34

Source: S&P Capital IQ. Standard template. Financial Sources.